About this trial
Clear cell renal cell carcinoma is diagnosed by imaging, sometimes associated with biopsy. This diagnosis is expensive, invasive and sometimes late. The development of a simple biological test for diagnosis is essential. Exosomes are 30 to 150 nm membrane vesicles secreted into the extracellular space by various living cells. These exosomes can be isolated from biological fluids, including urine. The recent study of urinary exosomes is a promising topic for analyzing tumor markers in urine. The investigator's goal is to develop a reliable technique for detecting tumor exosomes in urine in patients with clear cell renal cell carcinoma. The analysis of urinary exosomes could provide a new liquid biopsy tool for the early diagnosis of clear cell renal cell carcinoma.
Eligibility criteria
Qualifiers
All patients with renal mass requiring surgery (partial or total nephrectomy)
Social security affiliation
Signed informed consent
Unscheduled nephrectomy
Disqualifiers
Insufficient volume of urine sample (< 100 ml)
Patients with a urinary catheter
Patients under court-ordered guardianship or curators
Trial design
Treatments tested in this trial
- Urinary sample